Answers are grounded in this paper and cite their sources.
Low-dose disulfiram improves liver injury markers in rats, suggesting potential for antifibrotic effects.
Low-dose DSF demonstrated hepatoprotective effects through improvements in biochemical markers and hepatocyte morphology, but failed to significantly attenuate fibrosis. These findings suggest that lower DSF concentrations (< 25 mg/kg) may offer greater antifibrotic potential and should be further investigated in dose-response studies.
No takes yet. Share an insight, caveat, or question.
Rostami et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: